• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form FWP filed by AptarGroup Inc.

    11/17/25 4:47:35 PM ET
    $ATR
    Plastic Products
    Industrials
    Get the next $ATR alert in real time by email
    FWP 1 tm2529015d3_fwp.htm FWP

     

    Free Writing Prospectus
    Filed Pursuant to Rule 433
    Registration No. 333-276977
    Supplementing the preliminary prospectus supplement dated November 17, 2025

     

    AptarGroup, Inc.

     

    4.750% Senior Notes due 2031

     

    Pricing Term Sheet

     

    November 17, 2025

     

    Issuer: AptarGroup, Inc.
       

    Expected Ratings

    (Moody’s/S&P/Fitch)*:

    Baa2 (Stable Outlook) / BBB (Stable Outlook) / BBB (Stable Outlook)

       
    Format: SEC Registered
       
    Ranking: Senior Unsecured
       
    Principal Amount: $600,000,000
       
    Trade Date: November 17, 2025
       
    Settlement Date**: November 20, 2025 (T+3)
       
    Maturity Date: March 30, 2031
       
    Interest Payment Dates: Semiannually on March 30 and September 30 of each year, beginning March 30, 2026 (short first coupon)
       
    Benchmark Treasury: 3.625% UST due October 31, 2030
       
    Benchmark Treasury
    Price / Yield:
    99-18+ / 3.719%
       
    Spread to Benchmark Treasury: +105 basis points
       
    Yield to Maturity: 4.769%
       
    Coupon (Interest Rate): 4.750%
       
    Price to Public (Issue Price): 99.917%

     

     

     

     

    Optional Redemption:

    Prior to February 28, 2031 (one month prior to their maturity date) (the “Par Call Date”), the Issuer may redeem the notes at its option, in whole or in part, at any time and from time to time, at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of:

     

    ·      (a) the sum of the present values of the remaining scheduled payments of principal and interest on the notes to be redeemed discounted to the redemption date (assuming the notes matured on the Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate (as defined in the preliminary prospectus supplement under “Description of Notes — Optional Redemption”) plus 20 basis points less (b) interest accrued to, but not including, the date of redemption, and

     

    ·      100% of the principal amount of the notes to be redeemed,


    plus, in either case, accrued and unpaid interest thereon to, but not including, the redemption date.

     

    On or after the Par Call Date, the Issuer may redeem the notes at its option, in whole or in part, at any time and from time to time, at a redemption price equal to 100% of the principal amount of the notes being redeemed plus accrued and unpaid interest thereon to, but not including, the redemption date.

       
    Change of Control Repurchase Upon the occurrence of a “Change of Control Repurchase Event” (as defined in the preliminary prospectus supplement under “Description of Notes — Change of Control Repurchase Event”), unless the Issuer has exercised its right to redeem the notes, the Issuer will be required to make an offer to each holder of notes to purchase, at such holder’s option and on the terms described in the preliminary prospectus supplement under “Description of Notes — Change of Control Repurchase Event,” all or a portion of such holder’s notes at a purchase price equal to 101% of the principal amount thereof, plus accrued and unpaid interest, if any, to, but not including, the date of repurchase.

     

    Joint Book-Running Managers:

    J.P. Morgan Securities LLC

    PNC Capital Markets LLC

    SG Americas Securities, LLC

    Wells Fargo Securities, LLC

    BNP Paribas Securities Corp.

    BofA Securities, Inc.

    HSBC Securities (USA) Inc.

     

     

     

     

    Senior Co-Managers:

    BBVA Securities Inc.

    Deutsche Bank Securities Inc.

    U.S. Bancorp Investments, Inc.

       
    CUSIP / ISIN: 038336 AB9 / US038336AB93

     

     

    * Note: A securities rating is not a recommendation to buy, sell or hold securities and may be revised or withdrawn at any time.

     

    ** It is expected that delivery of the notes will be made to investors on or about November 20, 2025, which will be the third business day following the date hereof (such settlement being referred to as “T+3”). Under Rule 15c6-1 under the Exchange Act of 1934, as amended, trades in the secondary market are required to settle in one business day, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers of the notes who wish to trade the notes prior to the business day before their date of delivery will be required, by virtue of the fact that the notes will initially settle in T+3, to specify an alternate settlement cycle at the time of any such trade to prevent a failed settlement. Purchasers of the notes who wish to trade the notes prior to the business day before their date of delivery should consult their own advisors.

     

    The Issuer has filed a registration statement (including a prospectus and preliminary prospectus supplement) with the Securities and Exchange Commission (the “SEC”) for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, the preliminary prospectus supplement and the other documents the Issuer has filed with the SEC for more complete information about the Issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the Issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling J.P. Morgan Securities LLC at (212) 834-4533, PNC Capital Markets LLC at (855) 881-0697, SG Americas Securities, LLC at (855) 881-2108 or Wells Fargo Securities, LLC at (800) 645-3751.

     

    Any disclaimers or other notices that may appear below are not applicable to this communication and should be disregarded. Such disclaimers or other notices were automatically generated as a result of this communication being sent via Bloomberg or another email system.

     

     

     

     

    Get the next $ATR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATR

    DatePrice TargetRatingAnalyst
    11/3/2025Outperform → Mkt Perform
    William Blair
    9/4/2025$220.00Overweight
    KeyBanc Capital Markets
    1/7/2025$200.00Outperform
    Raymond James
    1/6/2025$173.00Buy → Neutral
    BofA Securities
    10/14/2024$155.00 → $215.00Hold → Buy
    Jefferies
    4/29/2024Mkt Perform → Outperform
    William Blair
    1/3/2024$125.00 → $150.00Neutral → Outperform
    Robert W. Baird
    1/20/2022$150.00 → $126.00Equal-Weight
    Morgan Stanley
    More analyst ratings

    $ATR
    SEC Filings

    View All

    AptarGroup Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

    8-K - APTARGROUP, INC. (0000896622) (Filer)

    11/20/25 4:30:57 PM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form 424B5 filed by AptarGroup Inc.

    424B5 - APTARGROUP, INC. (0000896622) (Filer)

    11/19/25 9:10:40 AM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form FWP filed by AptarGroup Inc.

    FWP - APTARGROUP, INC. (0000896622) (Subject)

    11/17/25 4:47:35 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    AptarGroup downgraded by William Blair

    William Blair downgraded AptarGroup from Outperform to Mkt Perform

    11/3/25 9:08:28 AM ET
    $ATR
    Plastic Products
    Industrials

    KeyBanc Capital Markets initiated coverage on AptarGroup with a new price target

    KeyBanc Capital Markets initiated coverage of AptarGroup with a rating of Overweight and set a new price target of $220.00

    9/4/25 8:59:59 AM ET
    $ATR
    Plastic Products
    Industrials

    Raymond James initiated coverage on AptarGroup with a new price target

    Raymond James initiated coverage of AptarGroup with a rating of Outperform and set a new price target of $200.00

    1/7/25 9:09:40 AM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Hudson Irene Elizabeth claimed ownership of 798 shares (SEC Form 3)

    3 - APTARGROUP, INC. (0000896622) (Issuer)

    11/10/25 2:13:29 PM ET
    $ATR
    Plastic Products
    Industrials

    Segment President Touya Gael sold $340,298 worth of shares (2,500 units at $136.12), decreasing direct ownership by 7% to 31,463 units (SEC Form 4)

    4 - APTARGROUP, INC. (0000896622) (Issuer)

    9/12/25 8:12:33 AM ET
    $ATR
    Plastic Products
    Industrials

    Chief Human Resources Officer Vinczeller Shiela sold $161,006 worth of shares (1,167 units at $137.97), decreasing direct ownership by 4% to 25,134 units (SEC Form 4)

    4 - APTARGROUP, INC. (0000896622) (Issuer)

    9/8/25 12:50:17 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aptar to Present at Jefferies Global Healthcare Conference on November 19, 2025

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, today announced its participation at the Jefferies Global Healthcare Conference on Wednesday, November 19, 2025. Stephan Tanda, President and CEO, will present at 7:00 a.m. Eastern Standard Time. Vanessa Kanu, Executive Vice President and CFO, and Gael Touya, President Aptar Pharma, will also be available. A live audio webcast and presentation materials will be available in the "Investors" section of the Company's website at www.aptar.com. About Aptar Aptar is a global leader in drug delivery and consumer product dosing, dispensing and protection technol

    11/11/25 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Reports Third Quarter 2025 Results

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, today reported the following third quarter results for the period ended September 30, 2025, as compared to the corresponding period of the last fiscal year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251030956269/en/Aptar Reports Third Quarter 2025 Results Third Quarter 2025 Highlights (Compared to the prior year quarter; see Non-GAAP section for full definitions; see reconciliation for Non-GAAP measures) Reported sales increased 6% and core sales increased 1% Strong product volume growth

    10/30/25 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Digital Health Announces FDA 510(k) Clearance for HeroTracker® Sense, a Connected Add-On Device for Metered-Dose Inhalers

    Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, today announced that the U.S Food and Drug Administration (FDA) has granted 510(k) clearance for HeroTracker® Sense as a Class II medical device. This milestone recognizes HeroTracker® Sense - a Bluetooth-enabled sensor - as an innovative connected add-on for pressurized Metered Dose Inhalers (pMDIs), transforming traditional inhalers into smart, data-driven devices for patients and healthcare professionals. Designed for individuals aged 12 and above, HeroTracker® Sense is compatible with several commonly prescribed asthma and chronic obstructive pulmonary disease (COPD) medications, includ

    10/16/25 8:00:00 AM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Leadership Updates

    Live Leadership Updates

    View All

    Aptar CFO, Robert (Bob) Kuhn, Has Decided to Step Down After 37 Years with the Company

    Aptar Names Vanessa Kanu, A Finance Veteran with Over 25 Years of Experience, as Next CFO AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that Bob Kuhn, Executive Vice President and Chief Financial Officer (CFO) since 2008, has decided to retire at the end of this year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240725873916/en/(Left to right) Bob Kuhn, Executive Vice President and Chief Financial Officer since 2008, has decided to retire at the end of 2024; Vanessa Kanu will become Executive Vice President and CFO on January 1, 2025,

    7/25/24 5:20:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Appoints Global Finance and Operations Veteran Sarah Glickman to its Board of Directors

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that Sarah Glickman, an accomplished leader with more than 30 years of global financial and operational experience, has joined its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230905451175/en/Sarah Glickman Joins Aptar's Board of Directors (Photo: Aptar) "We are pleased to welcome Sarah Glickman to our Board of Directors. Sarah's extensive knowledge of all aspects of corporate finance coupled with her global operational experience, including in the pharmaceutical industry

    9/5/23 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Appoints Julie Xing to its Board of Directors

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, announced today that Julie Xing has joined its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230220005172/en/Julie Xing Joins Aptar's Board of Directors (Photo: Aptar) With over 20 years of experience in pharmaceutical, medtech, digital health, biotech and diagnosis, Julie's leadership approach focuses on inspiring teams to deliver sustainable growth in challenging markets and healthcare environments. With her solid track record of business transformation in multiple g

    3/1/23 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Financials

    Live finance-specific insights

    View All

    Aptar Reports Third Quarter 2025 Results

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, today reported the following third quarter results for the period ended September 30, 2025, as compared to the corresponding period of the last fiscal year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251030956269/en/Aptar Reports Third Quarter 2025 Results Third Quarter 2025 Highlights (Compared to the prior year quarter; see Non-GAAP section for full definitions; see reconciliation for Non-GAAP measures) Reported sales increased 6% and core sales increased 1% Strong product volume growth

    10/30/25 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Increases Quarterly Dividend by Nearly 7% Signaling Continued Momentum and Long-Term Strength

    Following an increase of almost 10% a year ago AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.48 per share, an almost 7% increase from the previous dividend amount, bringing the new annualized dividend to $1.92 per share. The payment date is November 13, 2025, to stockholders of record as of October 23, 2025. Stephan B. Tanda, Aptar President and CEO, commented, "Given the strength of our business outlook, the sustained long-term growth we anticipate from our Pharma segment, and our continued strong performance across all key financial metrics, the Board of Dir

    9/8/25 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Reports Second Quarter 2025 Results

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported the following second quarter results for the period ended June 30, 2025, as compared to the corresponding period of the last fiscal year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250731446602/en/Aptar Reports Second Quarter 2025 Results Second Quarter 2025 Highlights (compared to the prior year quarter) Reported sales increased 6% and core sales increased 3% Reported net income increased 24% to $112 million and adjusted EBITDA increased 13% from the prior year to $218 million Rep

    7/31/25 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by AptarGroup Inc. (Amendment)

    SC 13G/A - APTARGROUP, INC. (0000896622) (Subject)

    2/13/24 4:58:57 PM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form SC 13G/A filed by AptarGroup Inc. (Amendment)

    SC 13G/A - APTARGROUP, INC. (0000896622) (Subject)

    2/12/24 3:08:10 PM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form SC 13G/A filed by AptarGroup Inc. (Amendment)

    SC 13G/A - APTARGROUP, INC. (0000896622) (Subject)

    2/12/24 11:53:37 AM ET
    $ATR
    Plastic Products
    Industrials